logo

COMPLEMENT-MEDIATED AND CYTOKINE-DRIVEN INFLAMMATORY MECHANISMS IN SUBCLINICAL MYOCARDIAL INJURY IN PATIENTS WITH ARTERIAL HYPERTENSION

Authors

  • Sharipov J.R

    Bukhara state medical institute, Uzbekistan, Bukhara, Gijduvan St
    Author

Keywords:

arterial hypertension, ischemic heart disease, subclinical myocardial injury, high-sensitivity troponin, immunoinflammation, cytokines, complement

Abstract

The article presents the results of a study of pro-inflammatory and complement-dependent mechanisms in patients with arterial hypertension (AH) and in those with combined pathology of AH and ischemic heart disease (IHD). A total of 78 patients were examined and divided into two groups: patients with isolated AH (Group I) and patients with AH complicated by IHD (Group II). The control group consisted of conditionally healthy individuals. The study included the analysis of pro-inflammatory cytokines (IL-6), C-reactive protein (CRP), and complement component C3a depending on the degree of subclinical myocardial injury assessed by high-sensitivity cardiac troponin (hs-cTn). It was found that an increase in hs-cTn levels is accompanied by a stepwise activation of inflammatory processes: IL-6 increased up to 4.9-fold, CRP up to 6.5-fold, and C3a up to 36.7-fold (p<0.001), reflecting pronounced activation of innate immunity and complement-dependent mechanisms. The highest levels of IL-6 and CRP were observed in patients with manifest IHD, whereas the peak activity of C3a was detected at the stage of pronounced subclinical myocardial injury.

References

1. Boc V., Blinc A., Boc A. The role of high-sensitivity cardiac troponin and ischemia modified albumin in cardiovascular diseases // International Journal of Molecular Sciences. – 2025. – Vol. 26(22). – P. 11214.

2. Liu X. et al. Global burden of hypertensive heart disease and ischemic heart disease: trends and projections // Global Health Research and Policy. – 2025.

3. Li T. et al. Extracellular vesicles and their role in cardiovascular diseases // Frontiers in Cardiovascular Medicine. – 2025.

4. Stougiannou TM et al. Stem cell mechanisms in ischemic heart disease and myocardial repair // Biology. – 2024.

5. Tehrani DM et al. High-sensitivity troponin and cardiovascular risk prediction // Journal of the American College of Cardiology. – 2023–2025.

6. Libby P. Inflammation in atherosclerosis: from pathophysiology to practice // Journal of the American College of Cardiology. – 2021.

7. Ridker PM et al. Anti-inflammatory therapy and cardiovascular risk reduction: IL-6 pathway insights // New England Journal of Medicine. – 2020.

Downloads

Published

2026-04-09